As our Boston products liability attorneys can explain, the use of a qualified and knowledgeable expert can significantly increase a plaintiff’s chance of obtaining complete financial recovery. Chapman, et al. v. The Procter & Gamble Dist., et al., an appeal heard by the United States Court of Appeals for the…
As our Xarelto attorneys have discussed on other blog entries, Johnson and Johnson, Bayer, U.S., and German drugmakers involved with the production and marketing of the drug are performing new studies to increase the profit potential for their flagship anticoagulant. According to a recent article from The Wall Street Journal,…
According to a recent Bloomberg article, Boston Scientific was found liable and ordered pay $73 million in connection with its Transvaginal Mesh (TVM) medical device. As our experienced vaginal mesh attorneys in Massachusetts can explain, the product involved in the lawsuit was the Obtryx sling. The Obtryx sling is a…
A plaintiff attorney’s failure to register for the multi-district litigation’s case management/electronic case file system resulted in the dismissal of the plaintiff’s case against the makers of menopause drug Prempro. The decision was recently upheld by the U.S. Court of Appeals for the Eighth Circuit in Freeman v. Wyeth, et…
A pain medication known as Darvocet has been on the market since 1972, when it first received approval from the U.S. Food & Drug Administration. Less than six years later, the medical community acknowledged a link between the drug (a combination of propoxyphene and acetaminophen) and heart trouble. The concerns…
When a patent expires on a medication, drug companies can produce generic versions of the drug to sell to the public. Unfortunately, this can create significant legal complications. In 2011, a court decision established that generic drugmakers cannot make changes to product labels even if the drugmaker is alerted to…
A recent story from wfmynews2.com takes a closer at the problems many total hip replacement patients are facing do to dangerous and defective artificial hips. As millions of Americans are undergoing total hip replacements members of the “hip generation” are having more problems than they did before surgery. DePuy manufactures…
A recent article in The New York Times examines the risks of Pradaxa. Pradaxa, like Xarelto, is among a relatively new class of blood-thinning drugs turning huge profits for the manufacturer. Patients who had been taking Warfarin, the traditionally prescribed medication to aid in the prevention of strokes, needed to…
Payne v. Novartis, an appeal argued before the United States Court of Appeals for the Sixth Circuit, involved a woman and her husband who sued Novartis, a drug manufacturer, for failing to warn her that its drugs could cause serious damage to her jaw. Those two drugs were Aredia and…
According to recent article in the Boston Business Journal, a technological innovation will allow partial and total knee replacement surgeries to be performed by a robotic arm. The company claims that this robotic arm sets them apart form companies such as Stryker, DePuy, and Zimmer. As your Boston knee replacement…